Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
American Heart Journal|June 1, 1990
Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.
Scientific Reports|July 30, 2022
Experimental study of the quantification of indocyanine green fluorescence in ischemic and non-ischemic anastomoses, using the SERGREEN software programX Serra-Aracil, A García-Nalda, B Serra-Gómez, et al.
Biochemical and Biophysical Research Communications|August 25, 2001
LL-Z1271alpha: an interleukin-1beta production inhibitorK Ichikawa, T Inagaki, H Kachi-Tonai, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Densely sampled stimulus-response map of human cortex with single pulse TMS-EEG and its relation to whole brain neuroimaging measuresYinming Sun, Molly V Lucas, Christopher C Cline, et al.
Journal of Vascular Surgery|January 1, 1986
Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activatorR A Graor, B Risius, J R Young, et al.
Journal of Vascular Surgery|February 1, 1988
Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary reportR A Graor, B Risius, J R Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Oxytocin enhances brain function in children with autismIlanit Gordon, Brent C Vander Wyk, Randi H Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimenT André, M A Bensmaine, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Bulletin Du Cancer|April 1, 1997
[Subcutaneous administration of interleukin-2 in ambulatory treatment of patients with metastatic renal cancer. Three-year results of the SCAPP I program]J M Tourani, C Jaillon-Abraham, V Lucas, et al.
Pageof 16